Good morning investors! The situation isn’t looking very good for the market as The Middle East conflict continues to worsen.
Today we cover:
What to expect this week
Eli Lilly signs a big deal
📊 Economy and News
What to Expect This Week
Here’s what you need to keep an eye on this week:
Monday, March 30
Key earnings: Progress Software (PRGS)
Markets remain focused on developments in the Iran conflict.
Tuesday, March 31
Consumer Confidence (March)
S&P Case-Shiller Home Price Index (January)
Chicago Business Barometer (March)
Fed speaker: Chicago Fed President Austan Goolsbee
Key earnings: Nike (NKE), McCormick & Co. (MKC), TD Synnex (SNX), nCino (NCNO)
Wednesday, April 1
U.S. Retail Sales (February)
ADP Private Payrolls (March)
ISM and S&P Manufacturing PMI (March)
Business Inventories (January)
Key earnings: Conagra Brands (CAG), Lamb Weston (LW), Cal-Maine (CALM)
Thursday, April 2
U.S. Trade Balance (February)
Initial Jobless Claims
Key earnings: Acuity (AYI), Lindsay Corp (LNN)
Friday, April 3
U.S. Employment Report (March) – Nonfarm Payrolls
ISM and S&P Services PMI (March)
Global hits:
Goldman becomes latest broker to turn cautious on NIFTY.
Swiss president says U.S. trade talks to continue beyond March.
U.S. and India remain split on WTO e-commerce moratorium extension.
Reminder: Trump calls for replacing Obamacare with direct payments to Americans.
📈 Stocks
S&P 500 6,368.85 (-1.67%)
DJIA 45,166.64 (-1.73%)
NASDAQ 20,948.36 (-2.15%)
BRENT CRUDE 115.4 (+2.54%)
* Prices as of Mar 30th, 12:20 AM UTC
Eli Lilly Strikes $2.75 Billion Deal with AI Drug Developer Insilico Medicine
U.S. pharmaceutical giant Eli Lilly has signed a $2.75 billion agreement with Hong Kong-based Insilico Medicine to develop and commercialize AI-discovered drugs globally.
The deal includes $115 million upfront, with the rest tied to regulatory and commercial milestones plus royalties on future sales.
The two companies have collaborated since a 2023 AI software licensing agreement. Insilico has created at least 28 drugs using generative AI, with nearly half already in clinical stages.
Insilico CEO Alex Zhavoronkov praised Lilly’s edge in integrating biology, chemistry, and automation, and noted that Insilico will join Lilly’s Gateway Labs biotech community.
The partnership aims to accelerate discovery of new therapies across multiple disease areas by combining Insilico’s AI platform with Lilly’s clinical development expertise.
Check this: Iran war is having negative effects on both restaurant demand and supply.
Judge blocks Pentagon’s effort to ‘punish’ Anthropic by labeling it a supply chain risk.
Surprising: Family caregivers now provide $1 trillion worth of care annually.
💵 Personal Finance
The Hidden Cost of Lifestyle Creep: Why Your Raise Isn’t Making You Richer
Many people celebrate a salary increase by upgrading their car, moving to a bigger apartment, or dining out more frequently. This phenomenon, known as lifestyle creep, quietly erodes financial progress. What feels like success often leaves individuals in the same net financial position—or worse—despite higher earnings.
Lifestyle creep occurs when increased income leads to proportionally higher spending. A $5,000 monthly salary might feel comfortable, but after a promotion to $7,000, new expenses quickly fill the gap: premium subscriptions, luxury vacations, and status-driven purchases. Psychologists link this to hedonic adaptation—humans quickly normalize better circumstances and seek more.
The long-term impact is significant. Someone earning $80,000 annually who experiences lifestyle creep may save only 5-8% of income, compared to 20-30% for those who maintain disciplined habits. Over 30 years, this difference can mean hundreds of thousands of dollars less in retirement savings due to lost compound growth.
To combat lifestyle creep, implement the “50/30/20 rule” with a twist: treat every raise as an opportunity to boost savings first. Automatically direct 50% of any pay increase into investments or high-yield savings before adjusting spending. Track expenses ruthlessly for 90 days after a raise to identify creeping costs.
Another strategy is “stealth wealth”—living below your means without broadcasting success. Drive the same reliable car, maintain modest housing, and focus on experiences rather than possessions. This approach preserves cash flow for wealth-building activities like maxing out retirement accounts or building an emergency fund covering 6-12 months of expenses.
Financial independence seekers often practice “intentional lifestyle optimization.” They question every recurring expense: Does this subscription truly add value? Could I negotiate a better rate on insurance or internet? Small wins compound dramatically over time.
Ultimately, true financial freedom comes not from earning more, but from keeping more. By consciously resisting lifestyle creep, individuals can transform salary increases into genuine wealth accumulation rather than temporary lifestyle upgrades. The discipline to live below your means while your income grows is one of the most powerful predictors of long-term financial success.
💰 Be a Better Investor
“The weakness of human nature prevents men from being good judges of their own deservings.”
What did you think of today's newsletter?
👩🏽⚖️ Legal Stuff
FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT ADVICE. Morning Download products and services are offered for educational and informational purposes only and should NOT be construed as a securities-related offer or solicitation or be relied upon as personalized financial advice. We are not financial advisors and cannot give personalized advice. There is a risk of loss in all trading, and you may lose some or all of your original investment. Results presented are not typical. This message may contain paid advertisements, or affiliate links. This content is for educational purposes only.
Please review the full risk disclaimer: MorningDownload.com/terms-of-use